Do increased intestinal permeability and low mucosal IgA promote allergic-type inflammation and mast-cell activation?

The intestinal mucosa maintains immune homeostasis through a cooperative defense system comprising secretory immunoglobulin A (sIgA) and tight junction barrier integrity. When these frontline defenses fail, the resulting immunological shift promotes allergic-type pathology.

Mechanistic explanations

• Loss of immune exclusion: Secretory IgA (sIgA) acts as the primary frontline defense, trapping and neutralizing luminal antigens within the mucus layer. Deficient sIgA allows unshielded dietary and microbial antigens to directly access and contact the epithelial surface.
• Barrier disruption and translocation: Under compromised conditions, zonulin-mediated disassembly of tight junction proteins, such as ZO-1, opens paracellular pathways. This enables intact antigens to translocate directly into the lamina propria, where they make contact with subepithelial immune cells.
• Inflammatory cascade: This excess antigen contact stimulates the rapid release of epithelial-derived alarmins, including TSLP, IL-25, and IL-33. These alarmins prompt local dendritic cells to prime naive CD4+ T cells toward a Th2 phenotype, which secrete IL-4, IL-5, and IL-13 to drive B-cell IgE class-switching.
• Mast cell feedback loop: Antigen exposure triggers IgE-FcεRI receptor cross-linking on mucosal mast cells, causing immediate degranulation and the release of preformed mediators like histamine, tryptase, and chymase. This system forms a self-perpetuating loop: released tryptase and chymase further degrade epithelial tight junctions, while epithelial IL-33 directly enhances mast cell survival and responsiveness.

Bottom line

• Deficient mucosal sIgA and increased intestinal permeability cooperatively permit unchecked antigen translocation. This direct contact with mucosal immune cells initiates and amplifies a self-reinforcing cascade of Th2-mediated allergic-type inflammation and mast-cell degranulation.